Hope Research Institute LLC

Peoria, Arizona 85381

0 studies enrolling now · 2 studies all time

What they study most

Diarrhea-predominant Irritable Bowel Syndrome, Gastroesophageal Reflux Disease (GERD)

Studies at this site

• Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Completed
• Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed